Influence of a Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) on Embryonic Aneuploidy Rate and Developmental Potential

计划入组 213 人 · 首次发布于 2009 年 1 月 15 日

Influence of a Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) on Embryonic Aneuploidy Rate and Developmental Potential

计划入组 115 人 · 首次发布于 2009 年 1 月 15 日

A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors

计划入组 345 人 · 首次发布于 2010 年 5 月 26 日

PDE3 inhibitor(Bayer)

PDE4 Inhibitors (Bionorica)

ALDH Inhibitor (Haimbio)

KalVista Pharmaceuticals

United States

Exelixis, Inc.

United States

Cytokinetics, Incorporated

United States

Heart Drug Cilostazol Shows Promise for Treating Growth Disorders in Preclinical Study

AirNexis Therapeutics Secures $200M Series A to Advance Dual PDE3/4 Inhibitor for COPD Treatment

Drug Hunter Highlights Key Pharmaceutical Patents and Clinical Updates from Late 2024